New book by Larry Connors Click here Improve your trading - See how
(Full text of statement. Contact details below.)
Federal Court of Australia Upholds Smith & Nephew's Appeal
Court overturns previous interlocutory injunction against Smith & Nephew's foam dressing kits in Australia
MELBOURNE, Australia, Oct. 10 /PRNewswire-AsiaNet/ -- Smith & Nephew Inc.'s Advanced Wound Management division (LSE: SN; NYSE: SNN | Quote | Chart | News | PowerRating) announced that the Federal Court of Australia has ruled in its favour and set aside KCI Medical Australia's (KCIMA) interlocutory injunction restraining Smith & Nephew from commercialising in Australia foam dressing kits for use in negative pressure wound therapy (NPWT). KCIMA has until 4 pm on Monday 12 October 2009 to seek a stay of the order setting aside the injunction while they seek to appeal the decision.
"We are very pleased with the outcome of the appeal and remain committed to providing a strong and diverse product portfolio, with which the clinician can exercise her or his own best judgment when tailoring NPWT for each patient," said Leon Hoare, President, Asia Pacific, Smith & Nephew Advanced Wound Management. "This is an important milestone for Smith & Nephew and follows a finding in the UK Court of Appeal that a corresponding UK patent is invalid."
KCIMA's claim against Smith & Nephew for patent infringement is vigorously contested by Smith & Nephew. Smith & Nephew is confident it will succeed at final trial at which it will argue that the patent is not valid under Australian law.
The RENASYS* NPWT product line includes the RENASYS GO and RENASYS EZ, as well as the RENASYS-G and RENASYS-F dressing kits. The RENASYS product line offers unmatched flexibility to support clinical judgment based on the unique needs of each wound, patient and care setting.
For more information regarding Smith & Nephew, please visit our Web site at www.smith-nephew.com.
Inquiries
Investors
Liz Hewitt
+44 (0)20 7401 7606
Group Director Corporate Affairs
Smith & Nephew
Press
Katie Cralle
+1 212 333 3810
Brunswick Group
Other Inquiries
Leon Hoare
+61 3 8540 6777
Smith & Nephew Healthcare
Advanced Wound Management
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were nearly $3.8 billion.
* Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.
SOURCE: Smith & Nephew Inc.
CONTACT: Investors, Liz Hewitt,
+44 (0)20-7401-7606,
Group Director Corporate Affairs, Smith & Nephew; or
Press, Katie Cralle,
+1-212-333-3810 , Brunswick Group; or
Other Inquiries,
Leon Hoare,
+61-3-8540-6777,
Smith & Nephew Healthcare, Advanced Wound Management
rw
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
